Basic fibroblast growth factor prevents the memory impairment induced by gastrin-releasing peptide receptor antagonism in area CA1 of the rat hippocampus

被引:17
作者
Preissler, Thales
Luft, Tatiana
Kapczinski, Flavio
Quevedo, Joao
Schwartsmann, Gilberto
Roesler, Rafael [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Pharmacol, Inst Basic Hlth Sci, Cellular & Mol Neuropharmacol Res Grp, BR-90046900 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Grad Program Biochem, Inst Basic Hlth Sci, Dept Biochem, BR-90035003 Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Bipolar Disorders Program, Acad Hosp Res Ctr, Fac Med, BR-90035003 Porto Alegre, RS, Brazil
[4] Univ So Santa Catarina, Lab Neurosci, Dept Med, BR-88806000 Criciuma, SC, Brazil
[5] Univ Fed Rio Grande do Sul, Fac Med, Dept Internal Med, BR-90035003 Porto Alegre, RS, Brazil
[6] Univ Fed Rio Grande do Sul, Acad Hosp Res Ctr, Canc Res Lab, BR-90035003 Porto Alegre, RS, Brazil
关键词
gastrin-releasing peptide receptor; basic fibroblast growth factor; RC-3095; hippocampus; memory consolidation;
D O I
10.1007/s11064-007-9320-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Increasing evidence indicates that the gastrin-releasing peptide receptor (GRPR) is implicated in regulating synaptic plasticity and memory formation in the hippocampus and other brain areas. However, the molecular mechanisms underlying the memory-impairing effects of GRPR antagonism have remained unclear. Here we report that basic fibroblast growth factor (bFGF/FGF-2) rescues the memory impairment induced by GRPR antagonism in the rat dorsal hippocampus. The GRPR antagonist [D-Tpi(6), Leu(13) psi(CH2NH)-Leu(14)] bombesin (6-14) (RC-3095) at 1.0 mu g impaired, whereas bFGF at 0.25 mu g enhanced, 24 h retention of inhibitory avoidance (IA) when infused immediately after training into the CA1 hippocampal area in male rats. Coinfusion with an otherwise ineffective dose of bFGF blocked the memory-impairing effect of RC-3095. These findings suggest that the memory-impairing effects of GRPR antagonists might be partially mediated by an inhibition in the function and/or expression of neuronal bFGF or diminished activation of intracellular protein kinase pathways associated with bFGF signaling.
引用
收藏
页码:1381 / 1386
页数:6
相关论文
共 42 条
[1]
Neurotrophic effect of basic fibroblast growth factor is mediated by the p42/p44 mitogen-activated protein kinase cascade in cultured rat cortical neurons [J].
Abe, K ;
Saito, H .
DEVELOPMENTAL BRAIN RESEARCH, 2000, 122 (01) :81-85
[2]
INVOLVEMENT OF PROTEIN-KINASE ACTIVATION IN NEUROTROPHIC EFFECTS OF BASIC FIBROBLAST GROWTH-FACTOR IN CULTURED BRAIN NEURONS [J].
ABE, K ;
IRI, Y ;
TAKAYANAGI, M ;
SAITO, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1991, 56 (04) :563-566
[3]
Effects of basic fibroblast growth factor on central nervous system functions [J].
Abe, K ;
Saitoh, H .
PHARMACOLOGICAL RESEARCH, 2001, 43 (04) :307-312
[4]
EFFECTS OF EPIDERMAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR ON GENERATION OF LONG-TERM POTENTIATION IN THE DENTATE GYRUS OF FIMBRIA-FORNIX-LESIONED RATS [J].
ABE, K ;
ISHIYAMA, J ;
SAITO, H .
BRAIN RESEARCH, 1992, 593 (02) :335-338
[5]
Potential usefulness of basic fibroblast growth factor as a treatment for stroke [J].
Ay, H ;
Ay, I ;
Koroshetz, WJ ;
Finklestein, SP .
CEREBROVASCULAR DISEASES, 1999, 9 (03) :131-135
[6]
Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers [J].
Bajo, AM ;
Schally, AV ;
Groot, K ;
Szepeshazi, K .
BRITISH JOURNAL OF CANCER, 2004, 90 (01) :245-252
[7]
Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: Possible involvement of the GABAergic system [J].
Dantas, Andrea dos Santos ;
Luft, Tatiana ;
Henriques, Joao Antonio Pegas ;
Schwartsmann, Gilberto ;
Roesler, Rafael .
PEPTIDES, 2006, 27 (09) :2307-2312
[8]
EFFECTS OF BOMBESIN AND GASTRIN-RELEASING PEPTIDE ON MEMORY PROCESSING [J].
FLOOD, JF ;
MORLEY, JE .
BRAIN RESEARCH, 1988, 460 (02) :314-322
[9]
Ghosh MM, 1995, BIOREMED SER, V3, P15
[10]
GIMENEZGALLEGO G, 1994, NEUROL RES, V16, P313